235 related articles for article (PubMed ID: 1939650)
1. Sjögren-Larsson syndrome. Deficient activity of the fatty aldehyde dehydrogenase component of fatty alcohol:NAD+ oxidoreductase in cultured fibroblasts.
Rizzo WB; Craft DA
J Clin Invest; 1991 Nov; 88(5):1643-8. PubMed ID: 1939650
[TBL] [Abstract][Full Text] [Related]
2. Carrier detection for Sjögren-Larsson syndrome.
Kelson TL; Craft DA; Rizzo WB
J Inherit Metab Dis; 1992; 15(1):105-11. PubMed ID: 1583866
[TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus vectors are able to restore fatty aldehyde dehydrogenase-deficiency. Implications for gene therapy in Sjogren-Larsson syndrome.
Haug S; Braun-Falco M
Arch Dermatol Res; 2005 Jun; 296(12):568-72. PubMed ID: 15834613
[TBL] [Abstract][Full Text] [Related]
4. Abnormal fatty alcohol metabolism in cultured keratinocytes from patients with Sjögren-Larsson syndrome.
Rizzo WB; Craft DA; Somer T; Carney G; Trafrova J; Simon M
J Lipid Res; 2008 Feb; 49(2):410-9. PubMed ID: 17971613
[TBL] [Abstract][Full Text] [Related]
5. Involvement of microsomal fatty aldehyde dehydrogenase in the alpha-oxidation of phytanic acid.
Verhoeven NM; Jakobs C; Carney G; Somers MP; Wanders RJ; Rizzo WB
FEBS Lett; 1998 Jun; 429(3):225-8. PubMed ID: 9662422
[TBL] [Abstract][Full Text] [Related]
6. Microsomal fatty aldehyde dehydrogenase catalyzes the oxidation of aliphatic aldehyde derived from ether glycerolipid catabolism: implications for Sjögren-Larsson syndrome.
Rizzo WB; Heinz E; Simon M; Craft DA
Biochim Biophys Acta; 2000 Dec; 1535(1):1-9. PubMed ID: 11113626
[TBL] [Abstract][Full Text] [Related]
7. Fatty aldehyde and fatty alcohol metabolism: review and importance for epidermal structure and function.
Rizzo WB
Biochim Biophys Acta; 2014 Mar; 1841(3):377-89. PubMed ID: 24036493
[TBL] [Abstract][Full Text] [Related]
8. Restoration of fatty aldehyde dehydrogenase deficiency in Sjögren-Larsson syndrome.
Haug S; Braun-Falco M
Gene Ther; 2006 Jul; 13(13):1021-6. PubMed ID: 16525484
[TBL] [Abstract][Full Text] [Related]
9. Sjögren-Larsson syndrome. Impaired fatty alcohol oxidation in cultured fibroblasts due to deficient fatty alcohol:nicotinamide adenine dinucleotide oxidoreductase activity.
Rizzo WB; Dammann AL; Craft DA
J Clin Invest; 1988 Mar; 81(3):738-44. PubMed ID: 3343337
[TBL] [Abstract][Full Text] [Related]
10. Prenatal diagnosis of Sjögren-Larsson syndrome using enzymatic methods.
Rizzo WB; Craft DA; Kelson TL; Bonnefont JP; Saudubray JM; Schulman JD; Black SH; Tabsh K; Dirocco M; Gardner RJ
Prenat Diagn; 1994 Jul; 14(7):577-81. PubMed ID: 7971759
[TBL] [Abstract][Full Text] [Related]
11. Diagnosing Sjögren-Larsson syndrome in a 7-year-old Moroccan boy.
Bernardini ML; Cangiotti AM; Zamponi N; Porfiri L; Cinti S; Offidani A
J Cutan Pathol; 2007 Mar; 34(3):270-5. PubMed ID: 17302612
[TBL] [Abstract][Full Text] [Related]
12. Sjögren-Larsson syndrome: inherited defect in the fatty alcohol cycle.
Rizzo WB; Dammann AL; Craft DA; Black SH; Tilton AH; Africk D; Chaves-Carballo E; Holmgren G; Jagell S
J Pediatr; 1989 Aug; 115(2):228-34. PubMed ID: 2666627
[TBL] [Abstract][Full Text] [Related]
13. Sjögren-Larsson syndrome.
Rizzo WB
Semin Dermatol; 1993 Sep; 12(3):210-8. PubMed ID: 8217559
[TBL] [Abstract][Full Text] [Related]
14. Bezafibrate induces FALDH in human fibroblasts; implications for Sjögren-Larsson syndrome.
Gloerich J; Ijlst L; Wanders RJ; Ferdinandusse S
Mol Genet Metab; 2006; 89(1-2):111-5. PubMed ID: 16837225
[TBL] [Abstract][Full Text] [Related]
15. Incomplete Sjögren-Larsson syndrome in two Japanese siblings.
Kawakami T; Saito R; Fujikawa Y; Kazama H; Shinomiya N; Yamaguchi K; Yamaguchi Y; Aoki T; Kobayashi T
Dermatology; 1999; 198(1):93-6. PubMed ID: 10026413
[TBL] [Abstract][Full Text] [Related]
16. Sjogren-Larsson syndrome associated hypermelanosis.
Xu YC; Hou JQ; Zhu WJ; Li P
J Cosmet Dermatol; 2020 Apr; 19(4):789-798. PubMed ID: 31697031
[TBL] [Abstract][Full Text] [Related]
17. A novel assay for the prenatal diagnosis of Sjögren-Larsson syndrome.
van den Brink DM; van Miert JM; Wanders RJ
J Inherit Metab Dis; 2005; 28(6):965-9. PubMed ID: 16435189
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of recombinant human fatty aldehyde dehydrogenase: implications for Sjögren-Larsson syndrome.
Lloyd MD; Boardman KD; Smith A; van den Brink DM; Wanders RJ; Threadgill MD
J Enzyme Inhib Med Chem; 2007 Oct; 22(5):584-90. PubMed ID: 18035827
[TBL] [Abstract][Full Text] [Related]
19. Identification of fatty aldehyde dehydrogenase in the breakdown of phytol to phytanic acid.
van den Brink DM; van Miert JN; Dacremont G; Rontani JF; Jansen GA; Wanders RJ
Mol Genet Metab; 2004 May; 82(1):33-7. PubMed ID: 15110319
[TBL] [Abstract][Full Text] [Related]
20. Isolation of animal cell mutants defective in long-chain fatty aldehyde dehydrogenase. Sensitivity to fatty aldehydes and Schiff's base modification of phospholipids: implications for Sj-ogren-Larsson syndrome.
James PF; Zoeller RA
J Biol Chem; 1997 Sep; 272(38):23532-9. PubMed ID: 9295289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
